key: cord-0897194-h1l7dpat authors: Hanson, Blake M.; Dinh, An Q.; Tran, Truc T.; Arenas, Sebastian; Pronty, Darryl; Gershengorn, Hayley B.; Ferreira, Tanira; Arias, Cesar A.; Shukla, Bhavarth S. title: Candida auris Invasive Infections during a COVID-19 Case Surge date: 2021-09-17 journal: Antimicrob Agents Chemother DOI: 10.1128/aac.01146-21 sha: 70fdad8aed4ea723cfc7b2821db5fe93fe9b4151 doc_id: 897194 cord_uid: h1l7dpat Clinical cases of C. auris noted during a COVID-19 surge led to an epidemiological, clinical, and genomic investigation. Evaluation identified a close genetic relationship but inconclusive epidemiologic link between all cases. Prolonged hospitalization due to critical illness from COVID-19 and use of antimicrobials may have contributed to clinical infections. occupation of a room in the same ward in the hospital. We were unable to conduct environmental sampling as our institutional and health department laboratory capacities were limited by the pandemic. Clinical isolates from the cohort were identified using matrix-assisted laser desorption/ionization time of flight (MALDI-ToF), while antifungal susceptibility testing was completed using Vitek2 by the clinical microbiology laboratory. Relevant clinical data, including demographics, comorbidities, prior antibiotic and steroid administration, and level of care, were abstracted from medical records. C. auris isolates were subjected to whole-genome sequencing on an Illumina MiSeq and a single isolate (index isolate, NC_1) was sequenced using an Oxford Nanopore MinION sequencer. Illumina-based assemblies were generated as previously described (4) , and the hybrid-assembly of NC_1 was generated using a bespoke pipeline (https://github.com/wshropshire/ flye_hybrid_assembly_pipeline). A core gene phylogenetic tree using a representative set of reference genomes was generated to assess phylogenetic clustering and confirm species identification, as previously described (5) . Single nucleotide polymorphisms (SNPs) were identified with GATK v4.1.9.0 (6) using the best practices workflow and NC_1 as an internal reference. A total of 15 clinical C. auris isolates, 12 from COVID-19 (C) patients and 3 from non-COVID-19 (NC) patients on separate wards, were recovered from blood and nonsterile sites (Table 1) . Only isolate C_1 displayed nonsusceptibility to all tested echinocandins. Antifungal susceptibility testing revealed that all isolates had amphotericin B MICs ranging from 0.5 to 1 mg/ml and were not susceptible to fluconazole (MIC $128 mg/ml). Isolation of C. auris followed a median hospital stay of 28 days from admission (interquartile range, 0 to 123 days), with 80% of patients in the cohort having critical illness requiring intensive care, mechanical ventilation, or use of vasopressor agents. All patients in the cohort received antibiotics, and all but one of the patients suffered from clinically relevant bacterial infections prior to isolation of C. auris. Steroids were administered as treatment in 83% of patients with COVID-19. Of the 15 patients in the cohort, C. auris was isolated from the bloodstream of 8 patients, and 6 patients had negative follow-up cultures after appropriate treatment. C. auris was identified for two of the patients posthumously. We established spaciotemporal epidemiological relationships in 12 cases between each patient and at least one other. Phylogenetic analyses revealed that all clinical isolates belonged to the South African lineage and were closely clustered, with every isolate differing by #5 SNPs relative to NC_1 ( Fig. 1 ), suggesting that this cluster originated from a single source and was disseminated by interpatient transmission or a point-source outbreak. However, no clear spaciotemporal link was identified in three of the cases, suggesting the possibility of community transmission or transmission between local health care or long-term-care facilities. Based on recently published known risk factors for C. auris acquisition (7), none of the cases in this cohort would have met screening criteria. To enhance disinfection, terminal cleaning, including ultraviolet C light (UV-C), was used in COVID-19 care wards. Of note, recent data suggest that UV-C may be less effective against decolonization of the environment by C. auris belonging to the South African clade (8) . Stresses during the surge and mixed messaging from local and national public health authorities led to changes in prescribing practices and perceptions of appropriate personal protective equipment (PPE) use, including extended and-at times-excessive use. This practice was compounded by the increase in use of agency nurses and staff with varied levels of training and experience in use of PPE and care of COVID-19 patients. Following the identification of the cluster, aggressive mitigation strategies were implemented, including expansion of C. auris screening to all patients arriving from any long-term-care facility, implementation of cleaning with hydrogen peroxide-based chemical and fogging disinfectants, repainting walls in rooms previously occupied by patients with C. auris, cohorting of patients and staff, standardization of COVID-19 PPE use aimed at minimizing potentially harmful overuse, removal of shared equipment, and enhanced guidance for antimicrobial use limited to defined indications. Once the local COVID-19 surge subsided, Experimental trials include avaptadil, mesenchymal stem cell therapy, or convalescent plasma. c "Critically ill" is signified by ICU admission, mechanical ventilation, and/or the use of vasopressor agents. a cessation of C. auris infections was observed. In summary, our results highlight the impending epidemic of multidrug-resistant organisms likely to emerge in the subsequent waves of the COVID-19 pandemic. As COVID-19 cases surge in different parts of the world, we urge a more judicious use of antimicrobials and steroids, as well as enhanced screening, surveillance, and isolation of patients colonized or infected with multidrug-resistant organisms, including C. auris . FIG 1 (A) Phylogenetic tree of Candida auris isolates (green) with 61 globally representative isolates demonstrating the four major C. auris clades. Outbreak isolates cluster with the African clade isolates. (B) Molecular epidemiological link between isolates and SNP distances between all isolates. The axes show a reciprocal list of the 15 outbreak isolates, and each cell represents the intersection between two isolates to show the epidemiological link (color) and the number of SNPs observed between the two isolates. Isolates demonstrating a common ancestor and putative transmission have either an epidemiologic link and/or a small number of SNPs. All isolates differ by #5 SNPs relative to the internal reference isolate NC_1, suggesting all isolates share a single common ancestor, and spread was due to either interpatient transmission or a point-source outbreak. The Pisa COVID-19 Study Group. 2021. Predictors of hospitalacquired bacterial and fungal superinfections in COVID-19: a prospective observational study Antibiotic resistance threats in the United States. U.S. Department of Health and Human Services Candida auris: a review of the literature Multi-Drug Resistant Organism Network Investigators. 2020. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the United StatesA (CRACKLE-2): a prospective cohort study IS26-mediated amplification of bla OXA-1 and bla CTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline Factors associated with Candida auris colonization and transmission in skilled nursing facilities with ventilator units Clade-specific variation in susceptibility of Candida auris to broad-spectrum ultraviolet C light We thank the members of the UHealth-DART Research Group for their support and feedback on this project.This study was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (K01AI148593 and P01AI152999 to B.M.H. and K24AI121296, R01AI134637, R01AI48342, and P01AI152999 to C.A.A.) and a University of Texas STARS Award to C.A.A. Supplemental material is available online only. SUPPLEMENTAL FILE 1, PDF file, 0.2 MB.